No connection

Search Results

PRPL

BEARISH
$0.63 Live
Purple Innovation, Inc. · NASDAQ
Target $2.45 (+289.5%)
$0.57 52W Range $1.26

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 18, 2026
Market cap
$68.33M
P/E
N/A
ROE
N/A
Profit margin
-11.0%
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
The company is in severe financial distress, evidenced by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -2.30, indicating negative shareholders' equity. While the company has maintained a healthy gross margin of 40.44% and modest revenue growth of 9.10%, these are overshadowed by consistent net losses and a catastrophic 5-year price decline of 98.2%. The lack of a Graham Number or Intrinsic Value calculation is a direct result of the company's negative earnings and equity. Overall, the deterministic health scores signal a high risk of insolvency.

Key Strengths

Healthy gross margin of 40.44%
Positive year-over-year revenue growth of 9.10%
Recent trend of beating quarterly earnings estimates (3 of last 4)
Extremely low Price-to-Sales ratio (0.15)
Current ratio of 1.35 provides a minimal short-term liquidity buffer

Key Risks

Negative shareholders' equity (P/B of -2.30) indicating insolvency risk
Severe financial instability as indicated by a Piotroski F-Score of 1/9
Chronic negative profit margins (-10.97%)
Poor liquidity profile with a Quick Ratio of 0.65
Extreme long-term value destruction (-98.2% over 5 years)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
12
Weak
Value
15
Future
30
Past
5
Health
10
Dividend
0
AI Verdict
High Risk / Distressed
Key drivers: Negative Equity, Piotroski F-Score 1/9, Long-term price collapse
Confidence
90%
Value
15/100

P/S of 0.15 is deceptive when equity is negative and earnings are absent.

Positives
  • Very low P/S ratio
Watchpoints
  • Negative P/B ratio
  • No Graham Number possible due to negative earnings
Future
30/100

Growth is present but insufficient to offset structural losses.

Positives
  • Modest revenue growth
  • Recent EPS beats
Watchpoints
  • Negative forward P/E
  • High PEG ratio (3.70)
Past
5/100

Consistent and severe destruction of shareholder capital.

Positives
No standout positives identified.
Watchpoints
  • 5Y Change: -98.2%
  • 3Y Change: -78.0%
Health
10/100

Deterministic health scores indicate a company in a state of failure.

Positives
  • Current Ratio > 1
Watchpoints
  • Piotroski F-Score 1/9
  • Negative Book Value
  • Quick Ratio < 1
Dividend
0/100

Company is not in a position to return capital.

Positives
No standout positives identified.
Watchpoints
  • No dividend history
  • 0/100 strength score

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.63
Analyst Target
$2.45
Upside/Downside
+289.5%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for PRPL and closest competitors.

Updated 2026-04-17
PRP
Purple Innovation, Inc.
Primary
5Y
-98.2%
3Y
-78.0%
1Y
+11.7%
6M
-25.3%
1M
-8.3%
1W
+3.0%
NOM
Nomadar Corp.
Peer
5Y
-65.3%
3Y
-65.3%
1Y
-65.3%
6M
-65.3%
1M
-18.1%
1W
-3.9%
KND
Kandi Technologies Group, Inc.
Peer
5Y
-86.3%
3Y
-70.3%
1Y
-34.1%
6M
-34.1%
1M
-12.9%
1W
-2.4%
PRT
CarParts.com, Inc.
Peer
5Y
-94.5%
3Y
-83.0%
1Y
+7.4%
6M
+35.9%
1M
+13.0%
1W
+13.0%
HOU
Hour Loop, Inc.
Peer
5Y
-76.5%
3Y
-1.1%
1Y
+64.9%
6M
-24.8%
1M
-1.1%
1W
+3.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-3.96
PEG Ratio
3.7
P/B Ratio
-2.3
P/S Ratio
0.15
EV/Revenue
0.53
EV/EBITDA
-20.39
Market Cap
$68.33M

Profitability

Profit margins and return metrics

Profit Margin -10.97%
Operating Margin -1.55%
Gross Margin 40.44%
ROE N/A
ROA -6.34%

Growth

Revenue and earnings growth rates

Revenue Growth +9.1%
Earnings Growth N/A
Q/Q Revenue Growth +9.08%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
1.35
Good
Quick Ratio
0.65
Poor
Cash/Share
$0.22

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.1B
Gross Margin
41.9%
Op. Margin
-1.6%
Net Margin
-2.3%
Total Assets
$0.3B
Liabilities
$0.3B
Equity
$-0.0B
Debt/Equity
-10.98x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
138%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-03-31
$-0.02
+63.6% surprise
2025-11-04
$-0.08
+17.9% surprise
2025-07-29
$-0.11
+8.3% surprise

Consumer Cyclical Sector Comparison

Comparing PRPL against 251 companies in the Consumer Cyclical sector (14 bullish, 84 neutral, 153 bearish)
Profit Margin
-10.97%
This Stock
vs
-5.14%
Sector Avg
+113.4% (Superior)
Revenue Growth
9.1%
This Stock
vs
15.78%
Sector Avg
-42.3% (Slower)
Current Ratio
1.35
This Stock
vs
2.46
Sector Avg
-45.3% (Weaker)

Similar Companies

Peer comparison within the same industry

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
CURRENT REPORT
2026-03-31

Propel Pharmaceuticals filed a Current Report on March 31, 2026, likely announcing its first-quarter financial results.

10-K
ANNUAL REPORT
2026-03-31

PRPL filed its Annual Report on March 31, 2026, which includes sections on business operations, financial condition, and risk factors. Specific financial highlights and risk details were not provided in the available excerpts.

8-K
CURRENT REPORT
2025-11-06
8-K
CURRENT REPORT
2025-11-04
10-Q
QUARTERLY REPORT
2025-11-04

Procept BioRobotics (PRPL) filed its quarterly report on November 4, 2025. While specific financial metrics were not provided in the excerpt, the filing includes a detailed discussion of risk factors under Item 1A.

8-K
CURRENT REPORT
2025-09-09
8-K
CURRENT REPORT
2025-08-12
10-Q
QUARTERLY REPORT
2025-07-30

PRPL filed its 10-Q quarterly report on July 30, 2025. While specific financial metrics were not provided in the excerpt, the filing includes a dedicated section for risk factors under Item 1A.

8-K
CURRENT REPORT
2025-07-29
8-K
CURRENT REPORT
2025-07-29
8-K
CURRENT REPORT
2025-07-23
8-K
CURRENT REPORT
2025-06-11
8-K
CURRENT REPORT
2025-05-06
10-Q
QUARTERLY REPORT
2025-05-06
8-K
CURRENT REPORT
2025-05-06
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
3 analysts
UBS
2026-04-01
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning PRPL from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile